TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $25,000 | -7.4% | 1,509 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $27,000 | 0.0% | 1,509 | 0.0% | 0.01% | +16.7% |
| Q4 2020 | $27,000 | -22.9% | 1,509 | -25.0% | 0.01% | -33.3% |
| Q3 2020 | $35,000 | -2.8% | 2,012 | 0.0% | 0.01% | -10.0% |
| Q2 2020 | $36,000 | +20.0% | 2,012 | 0.0% | 0.01% | +11.1% |
| Q1 2020 | $30,000 | -33.3% | 2,012 | -12.6% | 0.01% | -10.0% |
| Q4 2019 | $45,000 | +15.4% | 2,303 | 0.0% | 0.01% | +11.1% |
| Q3 2019 | $39,000 | -9.3% | 2,303 | -6.9% | 0.01% | -10.0% |
| Q2 2019 | $43,000 | +7.5% | 2,474 | +13.6% | 0.01% | +11.1% |
| Q1 2019 | $40,000 | – | 2,177 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |